Options Markets: How Far Have Implied Transaction Costs Fallen?
A key trend in the options markets over the last 20 years is the decline in trading commissions. In the early aughts, many brokerage groups charged $10 a trade. That…
Frontline Marketing “Innovation Coalition” Key To Generative AI Success For B2B Marketers
It is no exaggeration to say that generative AI (genAI) is everywhere these days, or that every function inside firms is scrambling to understand their company’s AI policies to avoid…
Nikola Stock Is Soaring Again After a Busy Week of News
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/nikola-stock-price-news-26ec7789 Updated Aug. 7, 2023 8:49 am…
ICE, Black Knight agree with FTC to dismiss court case against proposed deal By Reuters
© Reuters. FILE PHOTO: A screen displays the logo for Black Knight on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2022.…
Olaf Scholz under pressure to send cruise missiles to Ukraine
Receive free War in Ukraine updatesWe’ll send you a myFT Daily Digest email rounding up the latest War in Ukraine news every morning. German chancellor Olaf Scholz is under mounting…
WSJ Says a Housing Bust is Coming For Small-Time Investors—Here’s Why They Might Be Right
In this article Several days ago, the Wall Street Journal published an article about real estate syndicator Applesway Investment Group (owned by real estate entrepreneur Jay Gajavelli), which lost more…
HSBC top boss: Britain ‘weak’ for siding with the U.S.
A top executive at British bank HSBC said the U.K. was “weak” for siding with the U.S. in its tussles with China. Sherard Cowper-Coles, who serves as the head of…
Biggest stock movers today: Nikola and Yellow Corporation and more
Biggest stock movers today: Nikola and Yellow Corporation and more
Sage, Biogen receive setback despite FDA approval of postpartum depression drug. This is why By Investing.com
© Reuters Sage, Biogen receive setback despite FDA approval of postpartum depression drug. This is why The United States Food and Drug Administration (FDA) approved Zurzuvae (zuranolone), the first oral…
Time-Varying Risk Premia: Cochrane’s “Discount Rates”
“Asset prices should equal expected discounted cashflows. Forty years ago, Eugene Fama (1970) argued that the expected part, ‘testing market efficiency,’ provided the framework for organizing asset-pricing research in that…
